Results 231 to 240 of about 2,020,141 (269)
Some of the next articles are maybe not open access.
The Lancet, 2001
Vasopeptidase inhibitors are a new class of cardiovascular drug that simultaneously inhibit both neutral endopeptidase and angiotensin-converting enzyme (ACE). They increase the availability of peptides that have vasodilatory and other vascular effects; they also inhibit production of angiotensin II.
openaire +2 more sources
Vasopeptidase inhibitors are a new class of cardiovascular drug that simultaneously inhibit both neutral endopeptidase and angiotensin-converting enzyme (ACE). They increase the availability of peptides that have vasodilatory and other vascular effects; they also inhibit production of angiotensin II.
openaire +2 more sources
2012
In May 2003, the US Food and Drug Administration (FDA) granted accelerated approval for the use of the first-in-class proteasome inhibitor bortezomib as a third-line therapy in multiple myeloma, and the European Union followed suit a year later. Bortezomib has subsequently been approved for multiple myeloma as a second-line treatment on its own and as ...
openaire +2 more sources
In May 2003, the US Food and Drug Administration (FDA) granted accelerated approval for the use of the first-in-class proteasome inhibitor bortezomib as a third-line therapy in multiple myeloma, and the European Union followed suit a year later. Bortezomib has subsequently been approved for multiple myeloma as a second-line treatment on its own and as ...
openaire +2 more sources
1999
In this review we describe inhibition of chitinases from bacteria, fungi, plants and animals by allosamidin and its derivatives, cyclic peptides, styloguanidin and divalent cations. Most information is available for allosamidin, whose important structural features necessary for inhibition are known. At least one N-acetylallosamine sugar must be present,
K D, Spindler, M, Spindler-Barth
openaire +2 more sources
In this review we describe inhibition of chitinases from bacteria, fungi, plants and animals by allosamidin and its derivatives, cyclic peptides, styloguanidin and divalent cations. Most information is available for allosamidin, whose important structural features necessary for inhibition are known. At least one N-acetylallosamine sugar must be present,
K D, Spindler, M, Spindler-Barth
openaire +2 more sources
2014
Traditional treatments for cancer include chemotherapy, radiation therapy, and surgery. Recently, epigenetic inhibitors have been found to be very effective in cancer treatment. Epigenetic changes such as DNA methylation, histone deacetylation, and microRNA (miRNA) expression are capable of silencing the expression of tumor suppressor genes and ...
Mukesh, Verma, Hirendra Nath, Banerjee
openaire +2 more sources
Traditional treatments for cancer include chemotherapy, radiation therapy, and surgery. Recently, epigenetic inhibitors have been found to be very effective in cancer treatment. Epigenetic changes such as DNA methylation, histone deacetylation, and microRNA (miRNA) expression are capable of silencing the expression of tumor suppressor genes and ...
Mukesh, Verma, Hirendra Nath, Banerjee
openaire +2 more sources
[Motility inhibitors and secretion inhibitors].
Schweizerische medizinische Wochenschrift. Supplementum, 1985Antidiarrheal substances interfering with either intestinal motility or intestinal secretion have been used for the management of acute diarrhea. Opiates are the motility inhibitors that appear particularly useful and among these drugs loperamide is the drug of choice due to its low risk of side effects.
openaire +1 more source
2018
Advances in the field of corrosion inhibitors proceed in two main directions: (i) development of eco-friendly effective treatments and (ii) production of “smart” coatings. The first issue is connected to the more strict regulations regarding corrosion inhibitors application, due to environmental concerns.
openaire +1 more source
Advances in the field of corrosion inhibitors proceed in two main directions: (i) development of eco-friendly effective treatments and (ii) production of “smart” coatings. The first issue is connected to the more strict regulations regarding corrosion inhibitors application, due to environmental concerns.
openaire +1 more source